Discovery and biological evaluation of a novel class of dual microsomal prostaglandin E2 synthase-1/5-lipoxygenase inhibitors based on 2-[(4,6-diphenethoxypyrimidin-2-yl)thio]hexanoic acid.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2011-06-08

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/jm200092bPMID 21591611
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Structure of Human 5-Lipoxygenase

  2011cited by this paper
• The Molecular Pharmacology and In Vivo Activity of 2-(4-Chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid (YS121), a Dual Inhibitor of Microsomal Prostaglandin E2 Synthase-1 and 5-Lipoxygenase

  2010cited by this paper
• Self-organizing fuzzy graphs for structure-based comparison of protein pockets.

  2010cited by this paper
• Microsomal prostaglandin E synthase‐1 and 5‐lipoxygenase: potential drug targets in cancer

  2010cited by this paper
• Design, synthesis, and biological evaluation of a novel class of gamma-secretase modulators with PPARgamma activity.

  2010cited by this paper
• Eicosanoids and cancer

  2010cited by this paper
• Discovery of a novel class of 2-mercaptohexanoic acid derivatives as highly active PPARalpha agonists.

  2009cited by this paper
• Structural optimization and biological evaluation of 2-substituted 5-hydroxyindole-3-carboxylates as potent inhibitors of human 5-lipoxygenase.

  2009cited by this paper
• Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo

  2009cited by this paper
• Pirinixic acid derivatives as novel dual inhibitors of microsomal prostaglandin E2 synthase-1 and 5-lipoxygenase.

  2008cited by this paper
• Structural basis for induced formation of the inflammatory mediator prostaglandin E2

  2008cited by this paper
• Identification and functional analysis of cyclooxygenase-1 as a molecular target of boswellic acids.

  2008cited by this paper
• ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma

  2008cited by this paper
• Licofelone Suppresses Prostaglandin E2 Formation by Interference with the Inducible Microsomal Prostaglandin E2 Synthase-1

  2008cited by this paper
• Novel and potent inhibitors of 5-lipoxygenase product synthesis based on the structure of pirinixic acid.

  2008cited by this paper
• PocketPicker: analysis of ligand binding-sites with shape descriptors

  2007cited by this paper
• Mechanisms of disease: Leukotrienes

  2007cited by this paper
• Quinoline‐Based Derivatives of Pirinixic Acid as Dual PPAR α/γ Agonists

  2007cited by this paper
• Myrtucommulone from Myrtus communis induces apoptosis in cancer cells via the mitochondrial pathway involving caspase-9

  2007cited by this paper
• Antiprotozoal and antimicrobial activities of O-alkylated and formylated acylphloroglucinols.

  2007cited by this paper
• Quinoline-based derivatives of pirinixic acid as dual PPAR alpha/gamma agonists.

  2007cited by this paper
• 5-Lipoxygenase: regulation of expression and enzyme activity.

  2007cited by this paper
• Leukotrienes.

  2007cited by this paper
• Anti-inflammatory drugs in the 21st century.

  2007cited by this paper
• Development of 5-lipoxygenase inhibitors--lessons from cellular enzyme regulation.

  2005cited by this paper
• Recovering the true targets of specific ligands by virtual screening of the protein data bank

  2004cited by this paper
• 5-Lipoxygenase activation by MAPKAPK-2 and ERKs.

  2003cited by this paper
• Phosphorylation‐ and stimulus‐dependent inhibition of cellular 5‐lipoxygenase activity by nonredox‐type inhibitors

  2003cited by this paper
• Microsomal Prostaglandin E Synthase-1 Is a Major Terminal Synthase That Is Selectively Up-Regulated During Cyclooxygenase-2-Dependent Prostaglandin E2 Production in the Rat Adjuvant-Induced Arthritis Model

  2003cited by this paper
• Activation of 5-lipoxygenase by cell stress is calcium independent in human polymorphonuclear leukocytes.

  2002cited by this paper
• Arachidonic Acid Promotes Phosphorylation of 5-Lipoxygenase at Ser-271 by MAPK-activated Protein Kinase 2 (MK2)*

  2002cited by this paper
• Hyperforin is a dual inhibitor of cyclooxygenase-1 and 5-lipoxygenase.

  2002cited by this paper
• 5-lipoxygenase: cellular biology and molecular pharmacology.

  2002cited by this paper
• Cyclooxygenase‐1 and cyclooxygenase‐2 selectivity of non‐steroidal anti‐inflammatory drugs: investigation using human peripheral monocytes

  2001cited by this paper
• Anti-inflammatory drugs: new multitarget compounds to face an old problem. The dual inhibition concept.

  2001cited by this paper
• The Protein Data Bank

  2000cited by this paper
• Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target.

  1999cited by this paper
• Studies on anti-Helicobacter pylori agents. Part 1: Benzyloxyisoquinoline derivatives.

  1999cited by this paper
• Nonredox 5-lipoxygenase inhibitors require glutathione peroxidase for efficient inhibition of 5-lipoxygenase activity.

  1998cited by this paper
• Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation.

  1995cited by this paper
• Effect of a 5‐lipoxygenase inhibitor, ZM 230487, on cutaneous allergic inflammation in the guinea‐pig

  1994cited by this paper
• Selective inhibition of arachidonate 5‐lipoxygenase by novel acetohydroxamic acids: biochemical assessment in vitro and ex vivo

  1988cited by this paper
• Electronic Reprint Biological Crystallography the Protein Data Bank Biological Crystallography the Protein Data Bank

  year unknowncited by this paper

• Clinical data mining reveals analgesic effects of lapatinib in cancer patients

  2021cites this paper
• Research developments in the syntheses, anti-inflammatory activities and structure–activity relationships of pyrimidines

  2021cites this paper
• DREAM-in-CDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1

  2020cites this paper
• Inhibition of mPGES-1 as therapeutic strategy in inflammation and cancer

  2019cites this paper
• 3-26-2018 Structure-Based Discovery of mPGES-1 Inhibitors Suitable for Preclinical Testing in Wild-Type Mice as a New Generation of Anti-Inflammatory Drugs

  2019cites this paper
• In Silico Observation of the Conformational Opening of the Glutathione-Binding Site of Microsomal Prostaglandin E2 Synthase-1

  2019cites this paper
• Structure-based discovery of mPGES-1 inhibitors suitable for preclinical testing in wild-type mice as a new generation of anti-inflammatory drugs

  2018cites this paper
• Natural products as inhibitors of prostaglandin E2 and pro-inflammatory 5-lipoxygenase-derived lipid mediator biosynthesis.

  2018cites this paper
• Molecular mechanism of 15-lipoxygenase allosteric activation and inhibition.

  2018cites this paper
• Selective inhibitors of human mPGES-1 from structure-based computational screening.

  2017cites this paper
• Computational models for the classification of mPGES-1 inhibitors with fingerprint descriptors

  2017cites this paper
• RATIONAL DESIGN, SYNTHESIS, AND CHARACTERIZATION OF NOVEL mPGES-1 INHIBITORS AS NEXT GENERATION OF ANTI-INFLAMMATORY DRUGS

  2017cites this paper
• Nonsteroidal Anti‐Inflammatory Therapy: A Journey Toward Safety

  2017cites this paper
• Multiple target-centric strategy to tame inflammation.

  2017cites this paper
• 4. Synthesis of Organophosphines, Phosphonates, and Related Compounds

  2016cites this paper
• Design and Development of Microsomal Prostaglandin E2 Synthase-1 Inhibitors: Challenges and Future Directions.

  2016cites this paper
• Chemistry and biology of microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors as novel anti-inflammatory agents: recent developments and current status

  2016cites this paper
• Targeting microsomal prostaglandin E2 synthase-1 (mPGES-1): the development of inhibitors as an alternative to non-steroidal anti-inflammatory drugs (NSAIDs)

  2015cites this paper
• SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease.

  2015cites this paper
• Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.

  2015cites this paper
• Pirinixic acids: flexible fatty acid mimetics with various biological activities.

  2015cites this paper
• 4-substituted 2-chloromethyl[1,2,4]triazolo[1,5-a]benzimidazoles and their transformations

  2015cites this paper
• Spectral and Quantum-Chemical Study of Acid-Catalyzed Heterocyclization of S-(2-Chloroprop-2-EN-1-YL)Isothiuronium Chloride with Acetylacetone

  2014cites this paper
• Synthesis of new 2-(alkenylsulfanyl)pyrimidine derivatives

  2014cites this paper
• Aminothiazole-featured pirinixic acid derivatives as dual 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 inhibitors with improved potency and efficiency in vivo.

  2013cites this paper
• Discovery of Depsides and Depsidones from Lichen as Potent Inhibitors of Microsomal Prostaglandin E2 Synthase‐1 Using Pharmacophore Models

  2012cites this paper
• Designed multiple ligands: basic research vs clinical outcomes.

  2012cites this paper
• Structure-activity relationship of nonacidic quinazolinone inhibitors of human microsomal prostaglandin synthase 1 (mPGES 1).

  2012cites this paper
• Lead Optimization of Thiazolo[5,4‐c]piperidines: 3‐Cyclobutoxy Linker as a Key Spacer for H3R Inverse Agonists

  2012cites this paper
• Design and synthesis of a second series of triazole-based compounds as potent dual mPGES-1 and 5-lipoxygenase inhibitors.

  2012cites this paper
• Identification and development of mPGES-1 inhibitors: where we are at?

  2011cites this paper
• SAR studies of acidic dual γ-secretase/PPARγ modulators.

  2011cites this paper
• Evaluation of the Anti-Inflammatory Effects of Novel Pirinixic Acid Derivatives

  2011cites this paper